Table 2.
Total (N=7032) | Men (n=4073) | Women (n=2959) | P Value | |
---|---|---|---|---|
Age, y | 62.4±11.5 | 61.4±11.0 | 63.8±12.0 | <.001 |
Body mass index, kg/m2 | 27.6±4.8 | 27.9±4.2 | 27.0±5.4 | <.001 |
Waist circumference, cm | 96.5±13.5 | 100.4±11.9 | 91.2±13.7 | <.001 |
Current smoke, No. (%) | 1058 (15.3) | 760 (18.9) | 298 (10.3) | <.001 |
Systolic BP, mm Hg | 154.2±12.5 | 154.0±12.4 | 154.6±12.7 | .04 |
Diastolic BP, mm Hg | 89.6±9.1 | 89.8±9.0 | 89.3±9.1 | .03 |
Mean BP, mm Hg | 111.1±8.6 | 111.2±8.6 | 111.1±8.7 | .58 |
Pulse pressure, mm Hg | 64.6±12.0 | 64.2±11.8 | 65.3±12.3 | <.001 |
Heart rate, beats per s | 75.6±8.8 | 75.5±8.9 | 75.8±8.7 | .16 |
Plasma glucose, mmol/L | 6.98±1.57 | 7.08±1.56 | 6.85±1.59 | <.001 |
Hemoglobin A1c, % | 6.74±1.08 | 6.71±1.04 | 6.77±1.13 | .29 |
Total cholesterol, mmol/L | 5.38±1.04 | 5.35±1.06 | 5.44±1.00 | <.001 |
LDL cholesterol, mmol/L | 3.31±0.94 | 3.29±0.97 | 3.33±0.91 | .11 |
HDL cholesterol, mmol/L | 1.39±0.42 | 1.33±0.41 | 1.46±0.43 | <.001 |
Triglyceride, mmol/L | 1.20±0.27 | 1.22±0.27 | 1.18±0.27 | <.001 |
Diabetes mellitus, No. (%) | 1572 (22.8) | 955 (23.9) | 617 (21.2) | .008 |
Dyslipidemia, No. (%) | 2007 (35.1) | 1246 (37.8) | 761 (31.4) | <.001 |
Left ventricular hypertrophy, No. (%) | 753 (12.0) | 289 (12.7) | 298 (11.1) | .048 |
Coronary heart disease, No. (%) | 519 (7.8) | 387 (10.1) | 132 (4.7) | <.001 |
Microalbuminuria, No. (%) | 399 (7.1) | 257 (7.8) | 142 (6.1) | .01 |
Renal insufficiency, No. (%) | 328 (4.9) | 166 (4.3) | 162 (5.8) | .004 |
Antidiabetic therapy, No. (%) | 1537 (22.1) | 938 (23.3) | 599 (20.5) | .004 |
Antihyperlipidemic therapy, No. (%) | 3110 (44.7) | 1932 (47.9) | 1178 (40.3) | <.001 |
Antiplatelet therapy, No. (%) | 1947 (28.1) | 1247 (31.0) | 700 (24.0) | <.001 |
Abbreviations: BP, blood pressure; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein. Values are presented as mean±standard deviation or numbers (percentages). Disorders and therapy were defined by reading patients' medical document.